NORD & BIO Orphan Drug Tax Credit Report
Timeline highlighting milestones from NORD history
NORD 30th Anniversary Newsletter: Summer 2013
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs
(Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders)